PeptideStack
5.2kquestions
20kanswers
220users

How would I detect deamidation in a survodutide vial without sending it to Medutest?

Asked 28 Sept 2025Modified 7 months agoViewed 6.3k times
5

The case in front of me: deamidation · survodutide · Medutest.

I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.

I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer.

So: what is the actual procedure, and which steps matter as opposed to being ritual?

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
medutest
medutest

Medutest, one of four independent testing and verification services referenced throughout this site. Use this tag for its methods, its report…

126 questions
shareeditfollowflag
DK
askedDr_Tomas_Kral53k3828 Sept 2025
7Same question, and I got two answers that differ by a factor of ten, so I am watching this. – RP_C18 10 months ago
add a comment

5 Answers

Accepted answer first, then by votes
72

Accepted answer

Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.

Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.

Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.

A vial that passes inspection has passed a very weak test. It has not been verified.

Inspect before reconstitution. Afterwards you cannot tell whose particle it is.

shareimprove this answerflag
LC
answered · acceptedlyoph_cake78k26730 Nov 2025
The arithmetic checks out. I ran the same numbers and got the same result. – assay_blank 5 months ago
8Minor: the filter membrane chemistry matters as much as the pore size for adsorption. – sunniva_dahl 3 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
62

The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.

Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.

Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Passing inspection is a weak result. It rules out the obvious and nothing else.

shareimprove this answerflag
HP
answeredh_pergande71k15811 Dec 2025
25

The honest answer is that most defects found are cosmetic and the few that are not are obvious once you know the list.

Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.

On the detail: after reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.

Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.

The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.

The lot code has to be on the vial. A code on the box ties nothing to anything.

shareimprove this answerflag
HV
answeredh_villanueva70k488 Nov 2025
8Does this change at lower concentrations, or does adsorption start to dominate? – two_point_four 7 months ago
7Adding a vote because this deserves more of them. – Dr_Bram_Verhoeven 6 months ago
add a comment
23

Photograph anything unexpected before you touch it further; a photograph is the only evidence that survives.

Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.

Do not open a vial you intend to return or claim on; photograph it sealed first.

Crimp, stopper, label, contents. Light background and dark background.

shareimprove this answerflag
CI
answeredcake_intact17k2728 Oct 2025
-2

The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.

Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.

Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.

None of the above is a recommendation to administer anything. Research-use-only material is not approved for human use, and the arithmetic being correct does not make the decision safe.

Photograph anything unexpected before touching it further.

edited 19 Dec 2025 by pierce_count — clarified the distinction between purity and content

shareimprove this answerflag
PC
answeredpierce_count24k3819 Nov 2025
6Thank you — the worked example is what makes this usable. – sian_llewellyn 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.